Date: Spetember 14, 2021
Time: 9:00am (PDT), 12:00pm (EDT)
Pneumonia remains a major cause of morbidity and mortality. The use of broad-spectrum antibiotics is associated with the development of resistance, major side-effects and costs. Despite a higher sensitivity as compared to conventional microbiological diagnostics, molecular tests for bacterial lower respiratory infections are not well explored as a tool for enhancing antibiotic stewardship. This presentation will provide you the opportunity to review the rationale for using molecular diagnostics in bronchoalveolar lavage (BAL), to understand its role in the management of suspected lower respiratory tract infections, and to appreciate the newest results of a randomized trial evaluating the Unyvero multiplex bacterial PCR panel in BAL specimens to reduce inappropriate antibiotic therapy in patients hospitalized for pneumonia.
- Recognize the challenges associated with microbiological diagnosis of lower respiratory tract infections (LRTI).
- Discuss the new and available data on LRTI molecular testing and their important role in rapid and actionable diagnosis.
- Demonstrate the impact of molecular diagnostics in bronchoalveolar lavage (BAL) specimens for reducing inappropriate antibiotic therapy in pneumonia.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.